295 results
Prophylactic Rivaroxaban therapy for left ventricular thrombus after anterior ST segment elevation myocardial infarction
21 Apr 2022
The aim of the current study was to investigate the effects of rivaroxaban on left ventricle thromboprophylaxis in patients with anterior STEMI.
Reviewer
EROSION III: a multicenter RCT of OCT-guided reperfusion in STEMI with early infarct artery patency
19 Apr 2022
This is an interesting study showing that in patients with STEMI with early infarct artery patency, OCT guidance compared with angiographic guidance of reperfusion was associated with less stent implantation during primary PCI.
Reviewer
Short-term postoperative use of Rivaroxaban to prevent radial artery occlusion after transradial coronary procedure: the RESTORE randomized trial
14 Apr 2022
The RESTORE trial aimed to evaluate the clinical value of short-term postoperative anticoagulation with Rivaroxaban 10 mg daily for 7 days as compared with placebo, in reducing RAO at 24 hours and 30 days.
Reviewer
Reviewer
Randomized clinical trial on prevention of radial occlusion after transradial access using nitroglycerin: PATENS Trial
13 Apr 2022
The aim of the current study was to evaluate whether administration of nitroglycerin at the beginning or end of a trans-radial approach procedure would preserve radial artery patency.
Reviewer
Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry
11 Apr 2022
CRUNCH registry aimed to investigate the safety and efficacy of intravascular lithotripsy in the setting of resistant stent under expansion due to underlying calcific plaques.
Reviewer
Reviewer
Pre-treatment with P2Y12 inhibitors in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: a report from the Swedish Coronary Angiography and Angioplasty Registry
11 Mar 2022
The optimal timing of the administration of P2Y12 inhibitors in patients with CCS undergoing ad-hoc PCI is unknown. This study aimed to provide observational data to clarify these quandaries.
Reviewer
Reviewer
Sex differences in outcomes after percutaneous coronary intervention or coronary artery bypass graft for left main disease: from the DELTA registries
07 Mar 2022
The DELTA registry data provides real-world observational evidence that confirms what was reported in randomized trials: a higher rate of co-morbidities in women and better intermediate-term outcomes with CABG.
Reviewer
Risk of cardiovascular hospital admission after exposure to fine particulate pollution
23 Feb 2022
This current study explored the effect of heavy particle pollution on total cardiovascular admissions, whilst also looking at risk for specific cardiovascular diagnoses, such as angina, myocardial infarction, and ischaemic stroke.
Reviewer
Reviewer
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial
14 Feb 2022
The purpose of the prespecified subanalysis of the EXCEL (Evaluation of XIENCE versus Coronary artery bypass surgery for Effectiveness of Left main revascularization) trial was to determine whether the outcomes remained consistent regardless of geography.
Reviewer
Reviewer
One-year outcomes of blinded physiological assessment of residual ischemia after successful PCI - DEFINE PCI trial
10 Feb 2022
The objective of this analysis was to evaluate the impact of residual ischemia detected by post-PCI iFR on clinical outcomes and on residual-angina at the 12-month follow-up of the DEFINE PCI study.
Reviewer
Reviewer
